ArticleCurrent cancer drug targets2026

MiR-124-3p Suppresses Glioma Cells Progression by Targeting STAT3/NAMPT and Inhibiting AKT/ERK Signaling.

Yan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.